Andrew Fein Reiterated (UBX) at Strong Buy and Held Target at $10 on, Mar 16th, 2023

Show Stocks and Investing Publications

Thu, March 16, 2023

[ Thu, Mar 16th 2023 ]: WOPRAI

Serge Belanger Maintained (ARQT) at Strong Buy with Decreased Target to $24 on, Mar 16th, 2023

[ Thu, Mar 16th 2023 ]: WOPRAI

Jonathan Wolleben Maintained (AURA) at Buy with Decreased Target to $25 on, Mar 16th, 2023

[ Thu, Mar 16th 2023 ]: WOPRAI

Eric Joseph Maintained (AVIR) at Hold with Decreased Target to $8 on, Mar 16th, 2023

[ Thu, Mar 16th 2023 ]: WOPRAI

Joseph Pantginis Reiterated (CAPR) at Strong Buy and Held Target at $18 on, Mar 16th, 2023

[ Thu, Mar 16th 2023 ]: WOPRAI

Ashwin Shirvaikar Maintained (ACN) at Strong Buy with Decreased Target to $300 on, Mar 16th, 2023

[ Thu, Mar 16th 2023 ]: WOPRAI

Jason Kupferberg Maintained (ACN) at Strong Buy and Held Target at $350 on, Mar 16th, 2023

[ Thu, Mar 16th 2023 ]: WOPRAI

Robert Driscoll Reiterated (ACET) at Buy and Held Target at $30 on, Mar 16th, 2023

[ Thu, Mar 16th 2023 ]: WOPRAI

Edward White Reiterated (ACET) at Strong Buy and Held Target at $38 on, Mar 16th, 2023

[ Thu, Mar 16th 2023 ]: WOPRAI

David Tarantino Maintained (BJRI) at Hold with Decreased Target to $28 on, Mar 16th, 2023

[ Thu, Mar 16th 2023 ]: WOPRAI

Anupam Rama Maintained (ZLAB) at Buy with Decreased Target to $70 on, Mar 16th, 2023

[ Thu, Mar 16th 2023 ]: WOPRAI

Michael Turrin Maintained (ADBE) at Hold with Increased Target to $360 on, Mar 16th, 2023

[ Thu, Mar 16th 2023 ]: WOPRAI

Matthew Hedberg Reiterated (ADBE) at Buy and Held Target at $395 on, Mar 16th, 2023

[ Thu, Mar 16th 2023 ]: WOPRAI

Keith Bachman Maintained (ADBE) at Hold with Increased Target to $400 on, Mar 16th, 2023

[ Thu, Mar 16th 2023 ]: WOPRAI

Keith Weiss Maintained (ADBE) at Hold with Increased Target to $385 on, Mar 16th, 2023

[ Thu, Mar 16th 2023 ]: WOPRAI

Mark Murphy Maintained (ADBE) at Hold with Increased Target to $380 on, Mar 16th, 2023

[ Thu, Mar 16th 2023 ]: WOPRAI

Brent Bracelin Reiterated (ADBE) at Buy and Held Target at $415 on, Mar 16th, 2023

[ Thu, Mar 16th 2023 ]: WOPRAI

Constantine Davides Reiterated (VNRX) at Strong Buy and Held Target at $6 on, Mar 16th, 2023

[ Thu, Mar 16th 2023 ]: WOPRAI

Shelby Tucker Reiterated (WTRG) at Buy and Held Target at $54 on, Mar 16th, 2023

[ Thu, Mar 16th 2023 ]: WOPRAI

Scott Gruber Maintained (WTTR) at Hold with Decreased Target to $6.5 on, Mar 16th, 2023

[ Thu, Mar 16th 2023 ]: WOPRAI

Doug Anmuth Maintained (AMZN) at Buy with Decreased Target to $135 on, Mar 16th, 2023

[ Thu, Mar 16th 2023 ]: WOPRAI

Nicholas Jones Reiterated (AMZN) at Buy and Held Target at $140 on, Mar 16th, 2023

[ Thu, Mar 16th 2023 ]: WOPRAI

Curt Woodworth Maintained (STLD) at Buy with Increased Target to $106 on, Mar 16th, 2023

[ Thu, Mar 16th 2023 ]: WOPRAI

David Karnovsky Maintained (SRAD) at Buy with Decreased Target to $14 on, Mar 16th, 2023

[ Thu, Mar 16th 2023 ]: WOPRAI

Stephen Grambling Maintained (SRAD) at Hold with Decreased Target to $11 on, Mar 16th, 2023

[ Thu, Mar 16th 2023 ]: WOPRAI

David Katz Maintained (SRAD) at Hold with Increased Target to $11 on, Mar 16th, 2023

[ Thu, Mar 16th 2023 ]: WOPRAI

Bernie McTernan Maintained (SRAD) at Strong Buy with Decreased Target to $15 on, Mar 16th, 2023

[ Thu, Mar 16th 2023 ]: WOPRAI

Dan Dolev Upgraded (SQ) to Strong Buy and Increased Target to $93 on, Mar 16th, 2023

[ Thu, Mar 16th 2023 ]: WOPRAI

Joseph Stringer Reiterated (STOK) at Strong Buy and Held Target at $25 on, Mar 16th, 2023

[ Thu, Mar 16th 2023 ]: WOPRAI

Christopher Rolland Upgraded (SWKS) to Buy and Held Target at $135 on, Mar 16th, 2023

[ Thu, Mar 16th 2023 ]: WOPRAI

Chris Snyder Maintained (SWK) at Strong Buy with Decreased Target to $95 on, Mar 16th, 2023

[ Thu, Mar 16th 2023 ]: WOPRAI

Koichi Mamegano Upgraded (TAK) to Strong Buy and Held Target at $20 on, Mar 16th, 2023

[ Thu, Mar 16th 2023 ]: WOPRAI

Erik Suppiger Reiterated (BOX) at Buy and Held Target at $32 on, Mar 16th, 2023

[ Thu, Mar 16th 2023 ]: WOPRAI

Brian Kinstlinger Maintained (BOXL) at Strong Buy .. with Decreased Target to $1.75 on, Mar 16th, 2023

[ Thu, Mar 16th 2023 ]: WOPRAI

Scott Buck Reiterated (BOXL) at Strong Buy and Held Target at $16 on, Mar 16th, 2023

[ Thu, Mar 16th 2023 ]: WOPRAI

Gaurav Mehta Reiterated (BRT) at Strong Buy and Held Target at $25 on, Mar 16th, 2023

[ Thu, Mar 16th 2023 ]: WOPRAI

Alexandra Davis Maintained (BRCC) at Hold with Decreased Target to $6.5 on, Mar 16th, 2023

[ Thu, Mar 16th 2023 ]: WOPRAI

Sarang Vora Maintained (BRCC) at Buy with Decreased Target to $10 on, Mar 16th, 2023

[ Thu, Mar 16th 2023 ]: WOPRAI

Matthew Korn Maintained (BRLT) at Hold with Decreased Target to $5 on, Mar 16th, 2023

[ Thu, Mar 16th 2023 ]: WOPRAI

Michael Binetti Maintained (BRLT) at Buy with Decreased Target to $8 on, Mar 16th, 2023

[ Thu, Mar 16th 2023 ]: WOPRAI

Rick Patel Maintained (BRLT) at Buy with Decreased Target to $7 on, Mar 16th, 2023

[ Thu, Mar 16th 2023 ]: WOPRAI

Dana Telsey Reiterated (BRLT) at Buy and Held Target at $8 on, Mar 16th, 2023

[ Thu, Mar 16th 2023 ]: WOPRAI

Justin Patterson Maintained (BRLT) at Buy with Decreased Target to $6 on, Mar 16th, 2023

[ Thu, Mar 16th 2023 ]: WOPRAI

Lorraine Hutchinson Reiterated (BURL) at Strong Buy and Held Target at $250 on, Mar 16th, 2023

[ Thu, Mar 16th 2023 ]: WOPRAI

David Chiaverini Maintained (BUR) at Buy with Decreased Target to $13 on, Mar 16th, 2023

[ Thu, Mar 16th 2023 ]: WOPRAI

Blaine Heck Maintained (BXP) at Buy with Decreased Target to $64 on, Mar 16th, 2023

[ Thu, Mar 16th 2023 ]: WOPRAI

Matt Koranda Maintained (CDRE) at Strong Buy with Decreased Target to $28 on, Mar 16th, 2023

[ Thu, Mar 16th 2023 ]: WOPRAI

Bert Subin Maintained (CDRE) at Hold with Decreased Target to $25 on, Mar 16th, 2023

[ Thu, Mar 16th 2023 ]: WOPRAI

Michael Shlisky Upgraded (ALG) to Strong Buy and Increased Target to $196 on, Mar 16th, 2023

Andrew Fein Reiterated (UBX) at Strong Buy and Held Target at $10 on, Mar 16th, 2023

//stocks-investing.news-articles.net/content/202 .. -buy-and-held-target-at-10-on-mar-16th-2023.html

Published in Stocks and Investing on Monday, October 28th 2024 at 2:18 GMT by WOPRAI
^{🞛 This publication is a summary or evaluation of another publication}

Andrew Fein of HC Wainwright & Co., Reiterated "Unity Biotechnology, Inc." (UBX) at Strong Buy and Held Target at $10 on, Mar 16th, 2023.

Andrew has made no other calls on UBX in the last 4 months.

There is 1 other peer that has a rating on UBX. Out of the 1 peers that are also analyzing UBX, 0 agree with Andrew's Rating of Hold.

This is the rating of the analyst that currently disagrees with Andrew

Salim Syed of "Mizuho" Maintained at Strong Buy with Decreased Target to $12 on, Wednesday, November 16th, 2022